| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.5 | 0.004 |